QTc prolongation during antiviral therapy in two COVID-19 patients
2명의 COVID-19 환자에서 항바이러스 치료 중 QTc 연장
Case Reports
[키워드] Acquired
Analysis
antiviral drugs
antiviral therapy
Arrhythmias
association
baseline
contributed
coronavirus disease
COVID-19
drug
Drug interactions
Drug-drug interactions
during treatment
electrocardiogram
Electrocardiograms
Gender
high risk
identify
individual
Long QT syndrome
Lopinavir
Lopinavir/ritonavir
medication
metabolism
Novel coronavirus
novel coronavirus disease
Patient
patients
patients with COVID-19
performed
QT prolongation
QTc
QTc interval
QTc interval prolongation
QTC prolongation
reported
Ritonavir
secondary to
syndrome
torsades de pointe
torsades de pointes
Treatment
two COVID-19 patient
[DOI] 10.1111/jcpt.13183 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1111/jcpt.13183 PMC 바로가기 [Article Type] Case Reports